INTERNATIONAL PATENT: ADC THERAPEUTICS SA FILES APPLICATION FOR "ANTI-ASCT2 CONJUGATES"

GENEVA, April 28 -- ADC THERAPEUTICS SA (BiopoleRoute de la Corniche 3B1066 Epalinges) filed a patent application (PCT/EP2024/079214) for "ANTI-ASCT2 CONJUGATES" on Oct 16, 2024. With publication no. WO/2025/083064, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOGG, Paul (c/o ADC Therapeutics (UK) Ltd., I-HUB, Imperial College White City Campus, 84 Wood LaneLondon Greater London W12 0BZ), VEILLARD, Nicolas (c/o ADC Therapeutics (UK) Ltd., I-HUB, Imperial College White City Campus, 84 Wood LaneLondon Greater London W12 ...